Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / S&P BIOTECH
-
Total 13F shares
-
43,464,609
-
Share change
-
-8,492,229
-
Total reported value
-
$3,048,572,350
-
Put/Call ratio
-
244%
-
Price per share
-
$70.20
-
Number of holders
-
196
-
Value change
-
-$590,603,434
-
Number of buys
-
72
-
Number of sells
-
101
Institutional Holders of SPDR SERIES TRUST - S&P BIOTECH (XBI) as of Q4 2015
As of 31 Dec 2015,
SPDR SERIES TRUST - S&P BIOTECH (XBI) was held by
196 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
43,464,609 shares.
The largest 10 holders included
MORGAN STANLEY, GOLDMAN SACHS GROUP INC, JPMORGAN CHASE & CO, UBS Group AG, CITIGROUP INC, BANK OF AMERICA CORP /DE/, BNP PARIBAS ARBITRAGE, SA, CREDIT SUISSE AG/, STATE OF WISCONSIN INVESTMENT BOARD, and WELLS FARGO & COMPANY/MN.
This page lists
196
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.